Accessibility: Skip TopNav
Hemispherx Biopharma CEO Thomas K. Equels
Thomas K. Equels, CEO of Hemispherx Biopharma, announces latest company milestone.
Format
JPEG
Source
AIM ImmunoTech Inc.
Downloads
Original
Large
Medium
Small